ABSTRACT
Introduction Booster sessions are a potential method for maintaining self-management behaviors and treatment effects in people with chronic low back pain (LBP). However, few studies have examined booster prescription or outcomes in people with LBP.
Objective (1) Compare booster prescription for two exercise-based treatments for low back pain (LBP) in a randomized clinical trial (RCT) where the number of boosters prescribed was based on self-management program independence, (2) Determine if there are variables that predict who will require >1 booster, (3) Explore the effects of boosters on pain and function in people who required >1 booster.
Design Secondary analysis of a RCT in which participants were randomized to motor skill training (MST), MST+Boosters (MST+B), strength and flexibility exercise (SFE), or SFE+B.
Setting Academic research setting.
Participants 76 participants with chronic LBP assigned to receive boosters.
Interventions This secondary analysis focuses only on the MST+B and SFE+B groups. Both groups received 6 visits of MST or SFE and six months later received up to 3 boosters. The number of boosters was based on self-management program independence at the first booster. Those who required >1 booster were not able to independently perform their program at the first booster.
Main Outcome Measures Booster attendance and prescription, pain (Numeric Pain Rating Scale), function (modified Oswestry Disability Questionnaire)
Results There was not a significant difference between MST+B and SFE+B in returning for the initial booster, χ2(1)=1.76, p=0.185. SFE+B were more likely to require >1 booster than MST+B; β=2.39, p<0.001. No participant-specific factors we examined were statistically related to needing >1 booster.
Conclusion MST+B participants were less likely to require additional boosters. No additional participant-specific factors we examined were associated with needing additional boosters. Qualitatively, attending additional booster sessions did not appear to change pain or function in the current sample.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT02027623
Funding Statement
The study was supported by the NIH/NICHD/NCMRR [grant number R01 HD047709], QLH was supported by a training grant from the National Institutes of Health [grant number: TL1 TR002344]. We certify that no party having a direct interest in the results of the research supporting this article has or will confer a benefit on us or on any organization with which we are associated AND, if applicable, we certify that all financial and material support for this research (eg, NIH or NHS grants) and work are clearly identified in the title page of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Washington University School of Medicine Institutional Review Board (IRB#: 201205051) and all participants provided informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Financial Support: The study was supported by the NIH/NICHD/NCMRR [grant number R01 HD047709], QLH was supported by a training grant from the National Institutes of Health [grant number: TL1 TR002344]. We certify that no party having a direct interest in the results of the research supporting this article has or will confer a benefit on us or on any organization with which we are associated AND, if applicable, we certify that all financial and material support for this research (eg, NIH or NHS grants) and work are clearly identified in the title page of the manuscript.
Conflict of Interest Disclosures: Dr. van Dillen reports grant funding from the NIH, Academy of Orthopaedic Physical Therapy, and Advance Healthcare (Australia) during conduct of the study. Drs. Hooker and Lohse report grant funding from the NIH during conduct of the study. Dr. Lanier reports honoraria for teaching continuing education courses at University of Southern California and the California Physical Therapy Association. Dr. Civello reports no conflicts of interest. No other disclosures were reported.
Clinical Trial Registration: The primary trial from which this data was taken was registered on ClinicalTrials.gov (NCT02027623).
Ethical Approval: The study was approved by the Washington University School of Medicine Institutional Review Board (IRB#: 201205051) and all participants provided informed consent.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos